Unknown

Dataset Information

0

Serum sST2 levels predict severe exacerbation of asthma.


ABSTRACT: Neutrophilic inflammation is associated with poorly controlled asthma. Serum levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We hypothesized that high serum sST2 levels in stable asthmatics are a predictor for exacerbation within a short duration.This prospective observational study evaluated the serum sST2 levels of 104 asthmatic patients who were treated by a lung disease specialist with follow-ups for 3 months.High serum sST2 levels (>?18 ng/ml) predicted severe asthma exacerbation within 3 months. Serum sST2 levels correlated positively with asthma severity (treatment step), airway H2O2 levels, and serum IL-8 levels. High serum sST2 levels and blood neutrophilia (>?6000 /?l) were independent predictors of exacerbation. We defined a post-hoc exacerbation-risk score combining high serum sST2 level and blood neutrophilia, which stratified patients into four groups. The score predicted exacerbation-risk with an area under curve of 0.91 in the receiver operating characteristic curve analysis. Patients with the highest scores had the most severe phenotype, with 85.7% showing exacerbation, airflow limitation, and corticosteroid-insensitivity.High serum sST2 levels predicted exacerbation within the general asthmatic population and, when combined with blood neutrophil levels, provided an exacerbation-risk score that was an accurate predictor of exacerbation occurring within 3 months.

SUBMITTER: Watanabe M 

PROVIDER: S-EPMC6126416 | biostudies-other | 2018 Sep

REPOSITORIES: biostudies-other

altmetric image

Publications


<h4>Background</h4>Neutrophilic inflammation is associated with poorly controlled asthma. Serum levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We hypothesized that high serum sST2 levels in stable asthmatics are a predictor for exacerbation within a short duration.<h4>Methods</h4>This prospective observational study evaluated the serum sST2 levels of 104 asthmatic patients who were treated by a lung disease specialist with follow-ups for 3 months.<h4>Results</h  ...[more]

Similar Datasets

| S-EPMC8055991 | biostudies-literature
| S-EPMC10388125 | biostudies-literature
| S-EPMC7004419 | biostudies-literature
| S-EPMC10917146 | biostudies-literature
| S-EPMC6477157 | biostudies-literature
| S-EPMC5568982 | biostudies-literature
| S-EPMC7912443 | biostudies-literature
| S-EPMC7874466 | biostudies-literature
| S-EPMC6035773 | biostudies-literature
| S-EPMC9693242 | biostudies-literature